Inventiva S.A.(IVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

IVA Inventiva S.A.

Post-Mkt 12-05 19:32:55 EST

4.13

-0.05

-1.20%

盘后4.13

+0.000.00%

16:00 EST

High4.21	Low4.05	Vol147.98K
Open4.18	D1 Closing4.18	Amplitude3.83%
Mkt Cap788.83M	Tradable Cap470.82M	Total Shares191.00M
T/O611.09K	T/O Rate0.13%	Tradable Shares114.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"IVA","market":"US","secType":"STK","nameCN":"Inventiva S.A.","latestPrice":4.13,"timestamp":1764968400000,"preClose":4.18,"halted":0,"volume":147979,"hourTrading":{"tag":"盘后","latestPrice":4.13,"preClose":4.13,"latestTime":"16:00 EST","volume":53,"amount":218.89,"timestamp":1764968401751},"delay":0,"floatShares":113999999,"shares":191000000,"eps":-4.141533,"marketStatus":"Post-Mkt","change":-0.05,"latestTime":"12-05 19:32:55 EST","open":4.18,"high":4.21,"low":4.05,"amount":611090.7211,"amplitude":0.038278,"askPrice":4.21,"askSize":350,"bidPrice":4,"bidSize":130,"shortable":3,"etf":0,"ttmEps":-4.141533,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1764982800000},"marketStatusCode":4,"adr":0,"adrRate":1,"listingDate":1594353600000,"exchange":"NASDAQ","adjPreClose":4.18,"postHourTrading":{"tag":"盘后","latestPrice":4.13,"preClose":4.13,"latestTime":"16:00 EST","volume":53,"amount":218.89,"timestamp":1764968401751},"volumeRatio":0.747895},"requestUrl":"/m/hq/s/IVA","defaultTab":"news","newsList":[{"id":"2586209077","title":"Press Release: Results of the Votes of the Combined Shareholders' General Meeting of November 27, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2586209077","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586209077?lang=en_us&edition=fundamental","pubTime":"2025-11-28 15:30","pubTimestamp":1764315000,"startTime":"0","endTime":"0","summary":"Daix , New York City , November 28, 2025 -- Inventiva  , a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis , today announced the results of the votes of its Combined Shareholders' Meeting.The Combined Shareholders' Meeting was held on Thursday November 27, 2025, at 9 a.m. at Htel Villa M, 24-30 Bd Pasteur, 75015 Paris , under the chairmanship of Mr. Pierre Broqua.Mr. Pierre Broqua proceeded to the usual formalities of the opening of the meeting, in particular to the constitution of the Bureau by appointing Mr. Eric Duranson, as secretary of the general meeting.Pursuant to Article R. 22-10-14 IV. of the French Commercial Code, the Combined Shareholders' Meeting approved, without modification, the compensation policy for the Chief Executive Officer as described in the Combined Shareholders' Meeting notice brochure available on the Company's website under the heading \"Shareholders' ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2583586645","title":"Inventiva announves $125M American Depositary shares offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2583586645","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583586645?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:50","pubTimestamp":1762984252,"startTime":"0","endTime":"0","summary":"Inventiva (IVA) announced that it plans to offer and sell approximatively $125M of new American Depositary shares, or ADSs, each representing one n...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inventiva-announves-125m-american-depositary-shares-offering-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inventiva-announves-125m-american-depositary-shares-offering-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVA","AFG","BK4117","BK4107","BK4139"],"gpt_icon":0},{"id":"2581983486","title":"Inventiva S.A. Announces General Meeting for November 27, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2581983486","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581983486?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:28","pubTimestamp":1762550886,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Inventiva ( ($IVA) ). Inventiva S.A. announced that it will hold its Ordinary and Extraordinary General Meeting...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inventiva-s-a-announces-general-meeting-for-november-27-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inventiva-s-a-announces-general-meeting-for-november-27-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2581096519","title":"Inventiva Initiated at Outperform by Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2581096519","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581096519?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:33","pubTimestamp":1762435980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IVA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 06, 2025 08:33 ET (13:33 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2581674250","title":"Wolfe Research Initiates Coverage on Inventiva SA ADR With Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2581674250","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581674250?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:18","pubTimestamp":1762431504,"startTime":"0","endTime":"0","summary":"Wolfe Research Initiates Coverage on Inventiva SA ADR With Outperform Rating","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2581370721","title":"Inventiva initiated with an Outperform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2581370721","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581370721?lang=en_us&edition=fundamental","pubTime":"2025-11-06 05:36","pubTimestamp":1762378583,"startTime":"0","endTime":"0","summary":"Wolfe Research initiated coverage of Inventiva (IVA) with an Outperform rating and $13 price target Published first on TheFly – the ultimate source...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inventiva-initiated-with-an-outperform-at-wolfe-research-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inventiva-initiated-with-an-outperform-at-wolfe-research-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2579110790","title":"Canaccord Genuity Remains a Buy on Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2579110790","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579110790?lang=en_us&edition=fundamental","pubTime":"2025-10-30 19:12","pubTimestamp":1761822760,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Edward Nash from Canaccord Genuity maintained a Buy rating on Inventiva, with a price target of $20.00. The company...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-remains-a-buy-on-inventiva-iva-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-remains-a-buy-on-inventiva-iva-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2579953669","title":"Inventiva S.A. trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2579953669","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579953669?lang=en_us&edition=fundamental","pubTime":"2025-10-29 02:50","pubTimestamp":1761677426,"startTime":"0","endTime":"0","summary":"14:48 EDT Inventiva (IVA) S.A. trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-movin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inventiva-s-a-trading-halted-volatility-trading-pause-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inventiva-s-a-trading-halted-volatility-trading-pause-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2575240712","title":"Inventiva Files $300 Million Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2575240712","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575240712?lang=en_us&edition=fundamental","pubTime":"2025-10-15 05:22","pubTimestamp":1760476961,"startTime":"0","endTime":"0","summary":"Inventiva  filed a mixed shelf registration statement to raise $300 million from the sale of the company's securities, according to a Tuesday filing with the US Securities and Exchange Commission.The filing covers the potential sale of ordinary shares, American depositary shares representing ordinary shares, and warrants to purchase ordinary shares or ADSs.Inventiva said it plans to use proceeds to fund research and development of lanifibranor, as well as for working capital and general corporate purposes.The company also entered into a new at-the-market equity offering program to sell up to $100 million of ordinary shares in the form of ADSs, each representing one ordinary share. The amount is included in the total $300 million shelf registration.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2575242912","title":"Inventiva files $300M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2575242912","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575242912?lang=en_us&edition=fundamental","pubTime":"2025-10-15 04:10","pubTimestamp":1760472634,"startTime":"0","endTime":"0","summary":"16:07 EDT Inventiva (IVA) files $300M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inventiva-files-300m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inventiva-files-300m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2575212790","title":"European Equities Traded in the US as American Depositary Receipts Edge Lower Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2575212790","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575212790?lang=en_us&edition=fundamental","pubTime":"2025-10-14 23:19","pubTimestamp":1760455156,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were slightly lower on Tuesday morning, down 0.11% to 1,562.80 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by networking and telecoms company Ericsson  and cybersecurity company Wisekey , which climbed 17.4% and 14.4% respectively. They were followed by clinical-stage biopharmaceutical company Inventiva , which gained 6.7%.The decliners from continental Europe were led by Novo Nordisk  and Equinor , which fell 2.4% and 2.3% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Amarin  and semiconductor company Arm , which rose 3% and 2.6% respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Adaptimmune Therapeutics  and cryptocurrency miner Argo Blockchain , which dropped 17% and 8.7% respectively.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WKEY","BK4543","BK4201","IVA","BK4023","LU1093756325.SGD","LU1093756168.USD","BK4007","BK4141","ARM.AU","BK4107","IE00BZ1G4Q59.USD","BK4599","ADAP","BK4020","BK4588","BK4600","BK4565","BK4515","BK4532","IE00BMPRXQ63.HKD","IE00BMPRXR70.SGD","BK4591","ARBK","AMRN","ERIC","BK4595","AFG","BK4585","BK4554","BK4609","BK4139","BK7104","EQNR","LU0154236417.USD","LU0348723411.USD","LU2543165471.USD","NVO.AU","IE00BMPRXN33.USD","IE00BKVL7J92.USD","BK4117"],"gpt_icon":1},{"id":"2574178186","title":"Inventiva (IVA) Receives a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2574178186","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574178186?lang=en_us&edition=fundamental","pubTime":"2025-10-10 19:16","pubTimestamp":1760094985,"startTime":"0","endTime":"0","summary":"In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Inventiva, with a price target of $26.00. The company’s sh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/inventiva-iva-receives-a-buy-from-piper-sandler-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/inventiva-iva-receives-a-buy-from-piper-sandler-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2574166055","title":"Inventiva Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2574166055","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574166055?lang=en_us&edition=fundamental","pubTime":"2025-10-09 22:46","pubTimestamp":1760021160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IVA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 09, 2025 10:46 ET (14:46 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2574515814","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: PepGen Inc. (PEPG) and Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2574515814","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574515814?lang=en_us&edition=fundamental","pubTime":"2025-10-09 17:50","pubTimestamp":1760003431,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on PepGen Inc. (PEPG – Research Report) and Inventiva (IVA – Researc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-pepgen-inc-pepg-and-inventiva-iva-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-pepgen-inc-pepg-and-inventiva-iva-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4588","IVA","HCSG","PEPG","XBI","BK4585","BK4139","XLV","BK4581","LABU"],"gpt_icon":0},{"id":"1171232933","title":"Stock Track | Inventiva S.A. Soars 5.08% Following Canaccord Genuity's Buy Rating Reaffirmation","url":"https://stock-news.laohu8.com/highlight/detail?id=1171232933","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171232933?lang=en_us&edition=fundamental","pubTime":"2025-10-03 02:14","pubTimestamp":1759428860,"startTime":"0","endTime":"0","summary":"Inventiva S.A. (IVA) stock is soaring 5.08% in intraday trading, following a positive analyst report from Canaccord Genuity. The significant uptick comes as investors react to the reaffirmed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IVA"],"gpt_icon":0},{"id":"1134550637","title":"Stock Track | Inventiva S.A. Soars 5.08% Following Canaccord Genuity's Buy Rating Reaffirmation","url":"https://stock-news.laohu8.com/highlight/detail?id=1134550637","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134550637?lang=en_us&edition=fundamental","pubTime":"2025-10-03 02:14","pubTimestamp":1759428859,"startTime":"0","endTime":"0","summary":"Shares of Inventiva S.A. (IVA) experienced a significant uptick during Thursday's intraday trading, soaring 5.08% as investors responded positively to a recent analyst report. The surge in stock...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IVA"],"gpt_icon":0},{"id":"2572519674","title":"Canaccord Genuity Reaffirms Their Buy Rating on Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2572519674","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572519674?lang=en_us&edition=fundamental","pubTime":"2025-10-02 18:57","pubTimestamp":1759402620,"startTime":"0","endTime":"0","summary":"In a report released today, Edward Nash from Canaccord Genuity maintained a Buy rating on Inventiva, with a price target of $20.00. The company’s s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-inventiva-iva-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-inventiva-iva-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVA"],"gpt_icon":0},{"id":"2571325168","title":"Inventiva Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2571325168","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571325168?lang=en_us&edition=fundamental","pubTime":"2025-09-30 21:54","pubTimestamp":1759240440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IVA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 30, 2025 09:54 ET (13:54 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2571344127","title":"Inventiva (IVA) Gets a Buy from Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2571344127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571344127?lang=en_us&edition=fundamental","pubTime":"2025-09-30 19:36","pubTimestamp":1759232168,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Edward Nash maintained a Buy rating on Inventiva yesterday and set a price target of $20.00. The company’s shares closed ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/inventiva-iva-gets-a-buy-from-canaccord-genuity-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/inventiva-iva-gets-a-buy-from-canaccord-genuity-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2571349298","title":"Analysts Are Bullish on Top Healthcare Stocks: Larimar Therapeutics (LRMR), Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2571349298","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571349298?lang=en_us&edition=fundamental","pubTime":"2025-09-30 19:00","pubTimestamp":1759230012,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Larimar Therapeutics (LRMR – Research Report) and In...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-larimar-therapeutics-lrmr-inventiva-iva-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-larimar-therapeutics-lrmr-inventiva-iva-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4581","IVA","BK4588","BK4137","XLV","BK4112","LRMR","LABU","BK4139","BK4585","XBI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://inventivapharma.com","stockEarnings":[{"period":"1week","weight":-0.0913},{"period":"1month","weight":0.0372},{"period":"3month","weight":-0.2496},{"period":"6month","weight":0.1595},{"period":"1year","weight":0.5954},{"period":"ytd","weight":0.9533}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0574},{"period":"6month","weight":0.1423},{"period":"1year","weight":0.1263},{"period":"ytd","weight":0.1677}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.0537},{"month":2,"riseRate":0.6,"avgChangeRate":0.041998},{"month":3,"riseRate":0,"avgChangeRate":-0.105896},{"month":4,"riseRate":0.2,"avgChangeRate":-0.08167},{"month":5,"riseRate":0.6,"avgChangeRate":0.107821},{"month":6,"riseRate":0.2,"avgChangeRate":-0.118686},{"month":7,"riseRate":0.4,"avgChangeRate":-0.068338},{"month":8,"riseRate":0.333333,"avgChangeRate":0.149729},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.0365},{"month":10,"riseRate":0.666667,"avgChangeRate":0.071747},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.025201},{"month":12,"riseRate":0.666667,"avgChangeRate":0.015743}],"exchange":"NASDAQ","name":"Inventiva S.A.","nameEN":"Inventiva S.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inventiva S.A.(IVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Inventiva S.A.(IVA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Inventiva S.A.,IVA,Inventiva S.A.股票,Inventiva S.A.股票老虎,Inventiva S.A.股票老虎国际,Inventiva S.A.行情,Inventiva S.A.股票行情,Inventiva S.A.股价,Inventiva S.A.股市,Inventiva S.A.股票价格,Inventiva S.A.股票交易,Inventiva S.A.股票购买,Inventiva S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inventiva S.A.(IVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Inventiva S.A.(IVA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction